To further assess the effect of KDM3A knockdown on MM cell growth in vivo, we subcutaneously injected MM.1S cells transduced with shRNA against KDM3A or shLuc into severe combined immunodeficient (SCID) mice. This evidence concerns the gene KDM3A and Miyoshi myopathy.